Blue Owl Capital Corp issues $400 million in 6.450% notes due 2028

Blue Owl Capital Corp issued $400 million of 6.450% notes due 2028, with proceeds earmarked to pay down existing debt, including borrowings on its revolving credit facility. The company reported Q4 2025 EPS of $0.36 versus $0.37 expected and revenue of $439.5 million versus $450.88 million expected, a modest miss. The notes are unsecured, pay interest semiannually starting September 15, 2026, and are callable before maturity at a make-whole price or par plus accrued interest.

Analysis

This is less about headline earnings and more about liability management signaling. A BDC that can term out debt at 6.45% while still carrying a double-digit equity yield is effectively telling the market its cost of capital is no longer the constraint; the key question becomes whether incremental spread income can outrun funding costs and credit drift. The immediate beneficiary is the unsecured creditor stack, while the equity’s upside is capped if management keeps swapping floating-rate revolvers for fixed-rate notes without materially improving asset yields.

The second-order effect is on relative value across private credit vehicles. If Blue Owl can place size at institutional terms despite recent private-credit skepticism, that supports the “public/private” arbitrage for higher-quality managers, but it also raises the bar for weaker BDCs and private-credit funds that rely on cheaper leverage to juice ROE. Watch for compression in preferreds and baby bonds of peers as investors reprice refinancing risk versus underwriting quality over the next 1–2 quarters.

The market is likely underestimating how much this transaction is defensive rather than growth-oriented. Using proceeds to pay down the revolver reduces near-term liquidity risk, but it also telegraphs that management prefers balance-sheet resilience over aggressive portfolio expansion just as credit performance is becoming more scrutinized. If underwriting spreads in floating-rate assets soften or non-accruals tick up, the equity rerating thesis can unwind quickly even if reported EPS stays stable.

The contrarian view is that the bond issue is mildly constructive for equity because it de-risks the capital structure without forcing a dilutive equity raise. But that only works if credit marks hold; any deterioration in middle-market borrower health would make the higher fixed coupon a drag on distributable income over the next 12 months. In other words, this is a quality-of-earnings story, not a momentum story.

Key Decisions for Investors

• Long OBDC common vs short a basket of lower-quality BDCs (e.g., ARCC/FSK-relative underweighted basket) for 3-6 months: thesis is that stronger access to unsecured term funding should compress the funding-cost premium for higher-quality platforms while weaker names struggle to refinance.
• Buy OBDC baby-bond / note exposure rather than equity for 6-12 months: preferred risk-reward is better because the new issue strengthens de-leveraging and caps downside from modest credit slippage, while equity upside is constrained by NII sensitivity.
• Short high-yield BDC equity basket on any rally over the next 2-4 weeks: if Blue Owl’s deal is read as a sector-wide green light, that could be a fade; the better signal is selective capital access, not a broad risk-on repricing.
• For options traders: sell near-dated OBDC upside calls into strength and/or run a collar into the next earnings window; the stock likely trades on credit-spread updates, so upside is limited unless non-accruals improve materially.
• Monitor peers with heavier revolver reliance and maturities in 2027-2029; if their spreads widen over the next 1-2 quarters, rotate long OBDC vs short the weakest refinancing names.